79 Appendix Figure S1 . The metabolic phenotype of OXGR1 KO mouse on normal chow 80 (A). Schematic representation of OXGR1KO mouse line generation by Clustered Regularly 81
Interspaced Short Palindromic Repeats (CRISPR) strategy. The sgRNA sites were located in intron 82 3 and exon 4 of the OXGR1 gene. The DNA sequences contained sgRNA-binding regions are 83 labeled with red. 84 (B). The genomic sequencing of sgRNA target sites in wild-type and OXGR1KO mice. The 85 orange letter is the sgRNA target sequence. 86 (C). The validation of OXGR1KO mice. The mRNA expression of OXGR1 was determined in the 87 adrenal glands from male WT control (littermates) or OXGR1KO mice. 88 littlermates. Chow fed male mice (8 weeks of age) were monitored for 9 weeks (n = 8 per group). 90 (F-H). Representative images (F) of body composition and fat and lean mass (G) and tissue weight 91 (H) of male OXGR1KO mice after 9-weeks of monitoring (n = 8 per group). 92 (I). The body temperature of male OXGR1KO mice after 9-weeks of monitoring (n = 8 per 93 group). 94 (J-K). Representative images (J) and quantification (K) of BAT thermogenesis induced by 6 hrs 95 cold exposure at 4℃ in male OXGR1KO mice after 9-weeks of monitoring (n = 8 per group). mice were switched to HFD and received tap water or water supplemented with 2% AKG for 13 108 weeks (n = 8 per group). 109 (B). Immunoblots and quantification of UCP1 protein expression in the BAT of male OXGR1KO 110 mice treated with AKG for 13 weeks (n = 4 per group). 111 (C-D). Representative images (C) and quantification (D) of iWAT and gWAT HE staining from 112 male OXGR1KO mice treated with AKG for 13 weeks (n = 6 per group). 113 OXGR1KO mice treated with AKG for 13 weeks (n = 6 per group). 115 (G). The validation of OXGR1 reexpression. The mRNA expression of OXGR1 was determined in 116 the adrenal glands from male WT control, OXGR1KO injected with HBAAV2/9-GFP, and 117 OXGR1KO injected with HBAAV2/9-OXGR1 (OXGR1RE AG ) mice. 118 (H). Serum E level in male OXGR1RE AG . Male OXGR1KO mice (8 weeks) were 119 adrenal-specifically injected with control HBAAV2/9-GFP or HBAAV2/9-OXGR1. Two weeks 120 after injections, mice were switched to HFD and further divided into two groups, receiving tap 121 water or 2% AKG for 13 weeks. (n = 6 per group). in the adrenal glands from male WT control, WT injected with HBAAV2/9-GFP, and WT injected 138 with HBAAV2/9-OXGR1 (OXGR1OE AG ) mice (n=5 per group). 139 (B-C). Body weight gain (B) and cumulative food intake (C) of OXGR1OE AG . Male C57BL/6 140 mice (8 weeks) were adrenal-specifically injected with control HBAAV2/9-GFP or 141 HBAAV2/9-OXGR1. Two weeks after injections, mice were switched to HFD and further divided 142 into two groups, receiving tap water or water supplemented with 2% AKG for 12 weeks (n = 8 per 143 group). 
